Hht Foundation International, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hht.org
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Recruiting
- Conditions
- GastroIntestinal BleedingTelangiectasiaCerebral Arteriovenous MalformationsVascular MalformationEpistaxisHereditary Hemorrhagic TelangiectasiaArteriovenous Malformations
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Cure HHT
- Target Recruit Count
- 10000
- Registration Number
- NCT06259292
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Phase 1
Not yet recruiting
- Conditions
- Hereditary Hemorrhagic TelangiectasiaEpistaxis
- Interventions
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Cure HHT
- Target Recruit Count
- 30
- Registration Number
- NCT03850730
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
Phase 2
Active, not recruiting
- Conditions
- Hereditary Hemorrhagic TelangiectasiaNosebleedHHTEpistaxisAnemia
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Cure HHT
- Target Recruit Count
- 70
- Registration Number
- NCT03850964
- Locations
- 🇺🇸
University of California - Los Angeles, Los Angeles, California, United States
🇺🇸University of Colorado, Denver, Colorado, United States
🇺🇸Augusta University, Augusta, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath